As of 2024-07-27, the Relative Valuation of Agios Pharmaceuticals Inc (AGIO) is (192.40) USD. This relative valuation is based on P/E multiples. With the latest stock price at 48.05 USD, the upside of Agios Pharmaceuticals Inc based on Relative Valuation is -500.4%.
The range of the Relative Valuation is (191.06) - (196.03) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 30.8x - 35.0x | 31.3x |
| Forward P/E multiples | 29.0x - 31.6x | 30.6x |
| Fair Price | (191.06) - (196.03) | (192.40) |
| Upside | -497.6% - -508.0% | -500.4% |
| Date | P/E |
| 2024-07-26 | -7.74 |
| 2024-07-25 | -7.81 |
| 2024-07-24 | -7.76 |
| 2024-07-23 | -8.00 |
| 2024-07-22 | -7.69 |
| 2024-07-19 | -7.50 |
| 2024-07-18 | -7.68 |
| 2024-07-17 | -7.59 |
| 2024-07-16 | -7.74 |
| 2024-07-15 | -7.56 |
| 2024-07-12 | -7.39 |
| 2024-07-11 | -7.15 |
| 2024-07-10 | -7.00 |
| 2024-07-09 | -6.87 |
| 2024-07-08 | -6.63 |
| 2024-07-05 | -6.87 |
| 2024-07-03 | -6.77 |
| 2024-07-02 | -6.77 |
| 2024-07-01 | -6.98 |
| 2024-06-28 | -6.94 |
| 2024-06-27 | -7.02 |
| 2024-06-26 | -6.98 |
| 2024-06-25 | -7.19 |
| 2024-06-24 | -7.28 |
| 2024-06-21 | -7.28 |
| 2024-06-20 | -6.83 |
| 2024-06-18 | -6.85 |
| 2024-06-17 | -6.86 |
| 2024-06-14 | -7.10 |
| 2024-06-13 | -7.53 |
| 2024-06-12 | -7.72 |
| 2024-06-11 | -7.65 |
| 2024-06-10 | -7.60 |
| 2024-06-07 | -7.66 |
| 2024-06-06 | -7.70 |
| 2024-06-05 | -7.86 |
| 2024-06-04 | -7.62 |
| 2024-06-03 | -7.06 |
| 2024-05-31 | -5.85 |
| 2024-05-30 | -6.04 |
| 2024-05-29 | -6.12 |
| 2024-05-28 | -6.25 |
| 2024-05-24 | -5.07 |
| 2024-05-23 | -5.26 |
| 2024-05-22 | -5.38 |
| 2024-05-21 | -5.45 |
| 2024-05-20 | -5.34 |
| 2024-05-17 | -5.53 |
| 2024-05-16 | -5.63 |
| 2024-05-15 | -5.66 |